Legend Biotech (LEGN) Tops Q1 EPS by 3c

Legend Biotech (NASDAQ: LEGN) reported Q1 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $93.99 million versus the consensus estimate of $143.81 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge